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INTRODUCTION 
Meningitis is inflammation of the meninges (pia, arachnoid 
and duramater) covering the brain and the spinal cord. The most 
common cause of meningitis is infections due to viruses, bacteria, 
mycobacteria, fungi and other microorganisms. The Non-infectious 
causes include malignancy, chemical compounds, drugs and 
inflammatory conditions like CNS Sarcoidosis, SLE, Behcet’s 
syndrome, etc. Meningitis can also be classified according to the 
temporal profile as acute, sub acute and chronic types. 
Meningitis is a medical emergency as it can be life-threatening 
because of the inflammation’s proximity to brain and spinal cord. If 
not recognised earlier, it can lead to serious long term neurological 
sequelae like deafness, epilepsy, hydrocephalus and cognitive 
deficits. 
Lumbar puncture and CSF analysis is used to diagnose or 
exclude meningitis. Management involves prompt administration of 
antibiotics, and in appropriate situations, antiviral and anti- 
tuberculous agents according to the organism suspected. Steroids are 
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used as an adjunctive agent to prevent the complications from 
overactive inflammation. 
Tuberculous meningitis (TBM) is an endemic disease in 
developing countries with an incidence of 7-21%
 [19]
. It presents with 
gradual onset of symptoms and results in irreversible neurological 
complications and death if there is delay in diagnosis and start of 
effective treatment. But the available methods of diagnosis of TBM 
have too low sensitivity and specificity. Detection of acid fast bacilli 
(AFB) by light microscopy of the CSF smear is a rapid and specific 
method, but with a detection rate of only 30-40%
 [12]
. Sensitivity of 
mycobacterial culture on Lowenstein- Jensen (L-J) medium is higher 
than microscopy but it needs several weeks of incubation. A number 
of genotypic assays based on nucleic acid amplification have been 
designed
 [13]
. However, high costs involved in these tests preclude 
their use especially in developing countries.  
  In these situations, Adenosine Deaminase (ADA) estimation 
has been profoundly useful. ADA is an enzyme in the purine salvage 
pathway which is found in abundance in active T-lymphocytes. It is 
released by T cells during cell mediated immune response to the 
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tubercle bacilli. ADA levels have been considered by several 
researchers to differentiate tuberculous and nontuberculous diseases
 
[6, 9, 10, and 14]
. Its role in differentiating the tuberculous pleural, 
pericardial effusion and ascites from other causes has been well 
established. Several studies have also emphasized its importance as a 
simple, rapid, cost effective and fairly specific test in distinguishing 
TB meningitis from other causes of meningitis. Hence an attempt 
was made to estimate the CSF ADA level in patients with suspected 
meningitis and throw light on its use in differentiating the various 
types of meningitis. 
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REVIEW OF LITERATURE 
Central nervous system infections represent a continuing 
diagnostic and therapeutic problem in our country and frequently 
present as medical emergencies
 [3]
. 
When the infection predominantly involves the meninges and 
the subarachnoid space, it is known as meningitis. It presents with a 
characteristic combination of pyrexia, headache and meningism. 
Meningism consists of headache, photophobia and stiffness of the 
neck, often accompanied by other signs of meningeal irritation. 
Signs of Meningeal Irritation: 
Nuchal (cervical) rigidity is the most widely recognised and 
frequently encountered sign of meningeal irritation, and the 
diagnosis of meningitis is rarely made in its absence
 [1]
. It is 
characterised by stiffness and spasm of the neck muscles, with pain 
on attempted voluntary movement as well as resistance to passive 
movement. Nuchal rigidity primarily affects the extensor muscles, 
and the most prominent early finding in meningeal irritation is 
resistance to passive flexion. The physician is unable to place the 
patient’s chin on his chest, but the neck can be hyperextended; 
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rotatory and lateral movements may also be preserved. With more 
severe nuchal rigidity, retraction of the neck into a position of 
opisthotonus may occur. Rigidity may be absent in fulminating or 
terminal illness, when the patient is in coma, or in infants.  
Kernig’s and Brudzinski’s neck sign are other meningeal 
signs. To elicit Kernig’s sign, the more common method is to flex 
the hip and knee to right angles and then attempt to passively extend 
the knee
 [1]
. This movement produces pain, resistance, and inability 
to fully extend the knee. Kernig’s sign is positive in meningitis due 
to diffuse inflammation of the nerve roots and meninges. 
Brudzinski’s neck sign is as follows- placing one hand under the 
patient’s head and flexing the neck while holding down the chest 
with other hand causes flexion of hips and knees bilaterally
 [1]
.  
These meningeal signs depend on the activation of protective 
reflexes that shorten the spine and immobilise it thus reducing the 
stretch on inflamed spinal structures. Resistance to forward flexion 
of neck (Brudzinski’s sign) and extension of the legs (Kernig’s sign) 
involve manoeuvres that oppose these protective flexor reflexes
 [2]
. 
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To avoid spinal flexion, the patient with meningitis may sit in 
bed with the hands placed far behind, the head thrown back, the hips 
and knees flexed and the back arched  (Amoss’s, Hoyne’s or tripod 
sign)
[1]
.  
The severity of clinical features in meningitis varies according 
to the causative organism and CSF abnormalities help in 
distinguishing the cause of meningitis. Key goal of early 
management is to find out the causative organism and start a proper 
therapeutic regimen. 
Causes of Meningitis:  
       It can be broadly classified as infective and non-infective 
causes.               
Infective:                                                                                                 
Bacteria:                                                                                                               
Neonate   -  Gram-negative bacilli (Escherichia coli, 
 Proteus), Group B    Streptococci. 
Preschool child -  Haemophilus influenzae, Neisseria 
meningitidis.           
Older child/ Adult-  Streptococcus pneumoniae, Neisseria 
 meningitidis, Listeria monocytogenes.                                                        
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Viruses:  
Enteroviruses (Echo, coxsackie, polio ), Mumps, Influenza, 
Herpes Simplex, Varicella Zoster, Ebstein- Barr virus, HIV, 
Lymphocytic choriomeningitis, Mollaret’s meningitis (herpes 
simplex virus type 2). 
Protozoa and parasites :  Toxoplasma, Amoeba, Cysticercus.                                                                                                                                                                                                
Fungi   :  Cryptococcus neoformans, Candida, 
Histoplasma, Blastomyces, Coccidiodes, Sporothrix.                                                                           
Non-Infective:                                                                            
Malignant disease: Breast cancer, Bronchial cancer, 
Leukaemia,Lymphoma.                                                                                                    
Inflammatory disease: Sarcoidosis, SLE, Behcet’s disease. 
 Most of the bacterial and viral infections cause acute 
meningitis whereas most mycotic infections, tuberculosis, syphilis, 
lyme disease, HIV infection and presumed non-infectious causes 
such as lymphoma, Sarcoidosis, Wegener’s granulomatosis induce 
an inflammation of the leptomeninges of lesser intensity and more 
chronicity
[2]
. 
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BACTERIAL MENINGITIS: 
 Bacterial meningitis may be defined as bacterial invasion and 
subsequent inflammation of pia-arachnoid mater and exudation in 
cerebrospinal fluid (CSF) of the subarachnoid space
 [3]
. An organism 
entering this subarachnoid space can reach almost any part of brain 
and hence meningitis is almost always a cerebrospinal infection
 [2]
. 
Epidemiology/Etiology: 
  About 4-6 cases per 1, 00,000 adults worldwide are infected 
every year
 [3]
. Epidemiological data from India and other developing 
countries are lacking but the incidence is expected to be high. 
 The organisms most often responsible for community-acquired 
bacterial meningitis are Streptococcus pneumoniae, Neisseria 
meningitides, group B streptococci, Listeria monocytogenes and 
Haemophilus influenzae type b
 [4]
. In developed nations, following 
the introduction of effective vaccination, the frequency of meningitis 
caused by H.influenzae has declined by 82 percent
 [3]
. At present, 
pneumococcal and meningococcal meningeal infections 
predominate, especially in males. 
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 Pneumococcal meningitis occurs in the very young and in 
older adults. Pneumococcal lung and sinus infections predispose the 
patients to meningeal infection. 
Meningitis due to N.meningitidis has decreased with routine 
immunisation of 11 to 18 year olds with the tetravalent (serogroups 
A, C, W-135, and Y) meningococcal glycoconjugate vaccine. 
Presence of petechial or purpuric skin lesions provides an important 
diagnostic clue. Individuals with complement deficiencies are highly 
susceptible to meningococcal infections. 
 Enteric gram-negative bacilli cause meningitis in persons with 
diabetes, cirrhosis, alcoholism and in those with chronic UTI. Gram 
negative meningitis can also complicate neurosurgical procedures. 
 Listeria meningitis is associated with exceptionally high 
mortality. It causes meningitis in neonates, pregnant women and 
immunocompromised individuals.  
 Staphylococcus aureus and coagulase negative staphylococci 
are important causes of meningitis, that occurs following invasive 
neurosurgical procedures, particularly shunting procedures for 
hydrocephalus
 [2]
. 
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Pathogenesis: 
 The common infections causing meningitis are transmitted via 
air-borne route. Bacteria after colonising the nasopharyngeal mucosa 
secrete IgA protease enzymes that breakdown the protective mucous 
barrier allowing bacterial attachment to the epithelium. The outer 
adhesive bacterial pili also play an important role in the attachment 
of the encapsulated bacteria to the nasopharyngeal mucosa. After 
attachment, bacteria invade the adjacent intravascular space and gain 
access to the blood stream and finally enter the CSF through the 
choroid plexus of the lateral ventricles, and other points where blood 
brain barrier is weak. Once bacteria reach the CSF, they rapidly 
multiply because host humoral mechanisms in CSF are deficient
 [3]
. 
 Alternatively, bacterial meningitis can occur by 
haematogenous spread, through congenital neuroectodermal defects, 
craniotomy sites, middle ear diseases, paranasal sinus infections and 
skull fractures. 
 Meningitis associated brain injury and neuronal death is not 
mediated simply by the presence of viable bacteria but occurs as a 
consequence of the host inflammatory reaction to bacterial 
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components. Host inflammatory mediators include complement, 
tumour necrosis factor, interleukin-1, interleukin-6 and C-reactive 
protein. 
Stages in the pathogenesis of community- acquired bacterial 
meningitis: 
1. Nasopharyngeal colonisation 
2. Nasopharyngeal epithelial cell invasion 
3. Invasion of meningeal vessels 
4. Intravascular multiplication and bacteremia 
5. Crossing of blood brain barrier; bacterial entry into CSF 
6. Survival and multiplication in CSF 
Clinical Presentation: 
 The characteristic symptoms and signs of bacterial meningitis 
are headache, fever, nuchal rigidity, photophobia, vomiting and 
lethargy or an altered level of consciousness. Other signs of 
meningeal irritation (Kernig’s and Brudzinski’s signs) are also 
present in majority of the patients. Seizures occur in approximately 
23-40% of patients, typically in the first week of illness
 [3]
. Focal 
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neurological signs complicate bacterial meningitis in 15-28% of 
patients and are caused by cortical vein thrombosis, cerebral artery 
spasm, subdural empyema or rarely brain abscess
 [3]
. 
 Vestibulo-cochlear nerve is commonly affected in this type of 
meningitis resulting in sensorineural deafness, either unilateral or 
bilateral. It can appear early or late in the course of the disease and is 
usually permanent. Involvement of the 6
th
 and 7
th
 cranial nerves can 
occur at any time during the disease process and is probably never 
persistent. The presence of bilateral 6
th
 nerve palsies, suggest raised 
intracranial pressure. Papilloedema is rare; its presence usually 
suggests another diagnosis such as space-occupying lesion. 
 Other signs indicative of elevated intracranial pressure and 
cerebral herniation are coma, unilateral or bilateral fixed and dilated 
pupils, decorticate or decerebrate posture, abnormal respiration 
(cheynes-stokes breathing, hyperventilation, apnoea or respiratory 
arrest) and loss of oculo-cephalic reflex. These signs are often of 
ominous prognostic significance. 
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Diagnosis:  
 Blood cultures should be immediately obtained when there is 
suspicion of bacterial meningitis and empirical antibiotics and 
adjunctive dexamethasone therapy started without delay
 [4]
. If 
bacterial meningitis is suspected, lumbar puncture is an essential 
procedure. Prior to LP, CT/ MRI of the brain is necessary in patients 
in whom raised intracranial pressure or space- occupying lesion is 
suspected due to the presence of seizures, altered consciousness or 
papilloedema. 
CSF Abnormalities in Bacterial Meningitis: 
 CSF changes are characteristic of bacterial meningitis. 
Opening CSF pressure is often elevated usually in the range of 200-
500mm H2O. The CSF appearance may be turbid due to the presence 
of neutrophils. The WBC count in CSF is high, about 100 – 10,000 
cells/μL. Bacterial meningitis usually leads to a neutrophil 
predominance in CSF. The CSF glucose concentration is less than 
40mg/dl and the CSF to serum glucose ratio <0.4. The CSF protein 
concentration is increased >45mg/dl. Gram’s staining of CSF 
sediment is extremely important as it permits rapid and accurate 
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identification of the microorganism. The CSF culture is positive in 
approximately 70-85% of patients
 [3]
. The probability of CSF culture 
being negative is increased if patient has received prior antimicrobial 
therapy. Polymerase chain reaction (PCR) is especially useful in 
such situations. It helps by detecting the DNA of causative 
organisms. A rapid etiologic diagnosis is possible with the use of 
counter-current immunoelectrophoresis and such other serological 
techniques. These tests detect capsular antigen in CSF and are useful 
if CSF microscopy is negative, especially, if patient has already 
received antibiotics. 
Measurements of chloride concentrations in the CSF are not 
very useful but they are usually found to be low, probably reflecting 
dehydration and low serum chloride levels
 [2]
. In contrast, CSF 
lactate dehydrogenase (LDH), although infrequently measured, can 
be of diagnostic and prognostic value. A rise in total LDH activity is 
consistently observed in patients with bacterial meningitis, 
especially due to rise in fractions 4 and 5, which are derived from 
granulocytes. Fractions 1 and 2 of LDH, presumably derived from 
brain tissue, are only slightly elevated in bacterial meningitis but rise 
sharply in patients who develop neurologic sequelae or later die.  
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Imaging Studies: 
Chest films are essential in patients with bacterial meningitis 
because they may disclose an area of pneumonitis or abscess
 [2]
. 
Sinus and skull films may provide clues to the presence of cranial 
osteomyelitis, paranasal sinusitis or mastoiditis which are also better 
visualised on CT scans. The CT scan is particularly useful in 
detecting lesions that erode the skull or spine and provide a route for 
bacterial invasion, such as tumours or sinus wall defects, as well as 
in demonstrating a brain abscess or subdural empyema. MRI with 
gadolinium enhancement may display the meningeal enhancement 
and cortical reaction, and both types of imaging, with appropriate 
techniques will demonstrate venous occlusions and adjacent 
infarctions
 [2]
. 
Other Laboratory Findings: 
Blood cultures should be obtained because they are positive in 
40 to 60 percent of patients with H.influenzae, pneumococcal and 
meningococcal meningitis
 [3]
. The leukocyte count in blood is 
elevated, especially immature forms. Severe hyponatremia due to 
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inappropriate ADH secretion can complicate meningitis in later 
stages. 
Treatment: 
 Antibiotic therapy should be started soon after diagnosis is 
suspected or confirmed with characteristic CSF findings, without 
waiting to determine the causative organism.  
Empirical Antibiotic Therapy: 
 Choice of empirical antibiotic is determined on the basis of 
the patient’s age and underlying health status. Combination of 
vancomycin and a third- generation cephalosporin (ceftriaxone or 
cefotaxime) is the preferred antibiotic regimen for empirical 
treatment
 [3]
. Depending on the clinical scenario and suspected 
etiologic organism, drugs like acyclovir and doxycycline are added 
to the combination therapy
 [4]
. In young infants and older adults, in 
whom Streptococcus agalactiae and Listeria monocytogenes are 
prevalent; treatment with broad spectrum cephalosporins is 
supplemented with ampicillin. Metronidazole is added to cover 
gram-negative anaerobes in patients with otitis, sinusitis, or 
mastoiditis. Ceftazidime, cefepime, or meropenem is administered in 
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neurosurgical patients, as they provide coverage against 
P.aeruginosa. 
Pathogen Specific Therapy: 
Meningococcal meningitis: 
Penicillin G is the drug of choice for meningococcal 
meningitis caused by susceptible strains. Generally, high-dose 
intravenous penicillin-G should be administered every 4 to 6 hours 
for patients with invasive meningococcal disease. Acceptable 
alternatives are ampicillin, cefotaxime and ceftriaxone. 
Chloramphenicol is indicated for patients with anaphylactic allergic 
reactions to penicillin. 
Pneumococcal meningitis: 
As a result of increase in penicillin-resistant Streptococcus 
pneumoniae, adult patients with pneumococcal infection should 
receive ceftriaxone plus vancomycin unless organism is 
demonstrated to be cephalosporin-sensitive. Penicillin-sensitive 
species can be treated with continued cefotaxime, ceftriaxone, or 
chloramphenicol, or even switched to penicillin-G. For penicillin-
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resistant species, vancomycin is continued and rifampin may be 
added. 
Parenteral treatment is given for about 14 days. Patients with 
pneumococcal meningitis should have a repeat LP done after 24-36 
h after the initiation of antibiotics to document sterilisation of CSF. 
If there is failure of sterilisation, then it should be considered as 
presumptive evidence of antibiotic resistance. Patients with 
penicillin and cephalosporin resistance not responding to 
intravenous vancomycin may benefit from addition of 
intraventricular vancomycin
 [4]
. 
Listeria Meningitis: 
Ampicillin is the drug of choice for Listeria infection. 
Cotrimoxazole is given in penicillin allergic patients. 
Staphylococcal Meningitis: 
Nafcillin is the drug of choice in meningitis due to susceptible 
strains of S.aureus or coagulase-negative staphylococci. 
Vancomycin is administered in patients allergic to penicillin and in 
MRSA infections. 
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Gram-Negative Bacillary Meningitis: 
For Gram-negative bacilli a minimum treatment of three 
weeks is needed. Parenteral treatment with third generation 
cephalosporins is the treatment of choice. 
Adjunctive Therapy: 
Dexamethasone is an important part of adjunctive 
management of meningitis. Dexamethasone is administered 20 min 
before antibiotic therapy
 [4]
. Steroids help to decrease the 
inflammation associated with the disease process by inhibiting the 
production of cytokines. In paediatric population, the efficacy of 
steroids in reducing the complications of meningitis like deafness, 
focal neurological deficits has been well established. Despite 
conflicting results from earlier studies of corticosteroids in adults, 
recent trails have persuasively demonstrated a reduction in mortality 
and improved overall outcome if dexamethasone (10 mg 
intravenously) was administered 15-20 min before the first dose of 
antibiotic and the same dose  repeated every 6 h for 4 days. The 
improvement was largely in patients who were infected with 
pneumococcus. 
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Prognosis: 
  Untreated, bacterial meningitis is usually fatal. In treated H. 
Influenzae and meningococcal meningitis, the mortality rate is 
around 5 percent; in pneumococcal meningitis, the rate is higher (15 
percent)
 [2]
. A disproportionate number of deaths from meningitis 
occur in infants and in the aged. In adults, the presence of 
bacteremia, coma, seizures, and a variety of co-morbid conditions- 
diabetes mellitus, alcoholism, multiple myeloma, and head trauma- 
all worsen the prognosis. Death in meningitis may be attributed to 
the effects of overwhelming infection, with bacteremia, hypotension 
or brain swelling and cerebellar herniation especially during the first 
48 hrs. 
VIRAL MENINGITIS: 
 Viral meningitis is inflammation of the meninges due to a viral 
infection and in the majority of cases is a benign, self-limiting 
illness. 
 ‘Aseptic meningitis’ is a non-specific term indicating any form 
of meningitis where the CSF is bacteriologically sterile, 
accompanied by a lymphocytic pleocytosis and normal sugar content
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[3]
. Majority of cases are caused by viruses but a few cases are 
bacterial (mycoplasma, Q fever, other rickettsial infections)
 [2]
. 
Because aseptic meningitis is rarely fatal, the precise pathologic 
changes are uncertain but are presumably limited to the meninges 
Etiology: 
 The most common viruses causing meningitis are the 
Enteroviruses (poliovirus, coxsackie viruses, and echoviruses), HSV 
type 2, HIV, and arboviruses. Others are the lymphocytic 
choriomeningitis virus (LCMV), Epstein-Barr virus (EBV), 
influenza, adenovirus and the mumps virus.  
Epidemiology:   
Viral meningitis is not a nationally reportable disease. 
However, its incidence has been estimated around 75,000 cases per 
year
 [4]
. All age groups are susceptible, but it is more common in 
those below 30 years of age. The peak incidence of enteroviral 
infections is during the months of August and September
 [2]
. This is 
true also of infections caused by arboviruses. 
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Clinical Features: 
 Usually the onset is acute and the temperature is elevated, 
from 38 to 40°C. Headache that is more severe than that associated 
with other febrile states is the most frequent symptom. A variable 
degree of lethargy, irritability, and drowsiness may occur. 
Confusion, stupor, coma, and seizures mark the case as encephalitis 
rather than meningitis. Photophobia and pain on movement of the 
eyes are common additional complaints. Stiffness of the neck and 
spine on forward bending suggests the presence of meningismus, but 
at first it may be so slight as to pass unnoticed. Kernig’s and 
Brudzinski’s signs are often absent in the presence of manifest viral 
meningitis
 [2]
. Systemic symptoms and signs aside from fever are 
infrequent and depend mainly on the systemic effects of the virus. 
Laboratory Diagnosis: 
CSF Examination: 
CSF examination shows a clear fluid with mildly raised 
pressure, moderately increased protein, normal sugar content and 
pleocytosis ranging from 50-500 cells/mm
3
. Organisms are not seen 
on Gram’s stain of CSF. Usually the pleocytosis is mononuclear 
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except in the first 48 h of illness, when more than half the cells may 
be neutrophils, especially with infections due to echovirus 9, West 
Nile virus or mumps
 [2, 3]
. High CSF cell counts in thousands is seen 
in LCMV and mumps and CSF glucose may be mildly reduced in 
LCMV, mumps, HSV-2, and VZV. 
Nucleic acid amplification (PCR): 
  In Enteroviral and Herpes simplex virus infections of the 
CNS, PCR has become the diagnostic procedure of choice and more 
sensitive than viral culture. The other viruses that can be identified 
with PCR are cytomegalovirus (CMV), Ebstein- Barr virus (EBV), 
VZV, and human herpes virus (HHV-6)
 [4]
. 
Viral culture: 
Viral culture for the diagnosis of viral meningitis is possible 
sometimes. Specific viruses may also be isolated from throat swabs, 
stool, blood and urine, apart from CSF. 
Serology: 
 Demonstration of virus-specific IgM antibodies in serum also 
suggest acute infection and if such antibodies are found in the CSF, 
acute CNS infection may be presumed. Seroconversion, however 
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does not occur immediately and in most instances, the diagnosis is 
made retrospectively by measuring the viral antibody levels in the 
acute and convalescent phases.  
A four-fold increase in specific antibody titres in acute and 
convalescent serum or CSF is considered to be positive and even 
IgM antibodies may persist for months in the CSF and serum
 [3]
. CSF 
oligoclonal gamma globulin bands occur in association with a 
number of viral infections, the associated antibodies often directed 
against viral proteins
 [4]
. 
Other laboratory studies: 
Neuroimaging studies (MRI, CT) are not necessary in patients 
with uncomplicated viral meningitis, but should be performed in 
patients with altered sensorium, cranial nerve palsies or atypical CSF 
profile. 
Specific Viral Etiologies: 
Enteroviruses account for >85% of cases in which a specific 
etiology can be identified. These viruses cause meningitis in the 
summer and fall months, especially in children (< 15 years)
 [2, 4]
. 
Familial outbreaks are usual. A number of echovirus and 
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coxsackievirus (particularly group A) infections are associated with 
exanthemata and may be associated with the greyish vesicular 
lesions of oral herpangina
 [2]
. Pleurodynia, brachial neuritis, 
pericarditis, and orchitis are characteristic of some cases of group B 
coxsackievirus infections. Pain in the back and neck and in the 
muscles should suggest poliomyelitis. Lower motor weakness may 
occur with echo and coxsackievirus infections, but it is usually mild 
and transient in nature. Treatment is supportive and patients recover 
without sequelae. 
Arboviral infections cause encephalitis rather than meningitis. 
Japanese encephalitis is arboviral encephalitis caused by a flavivirus. 
It is one of the most common causes of epidemic encephalitis in 
India. Children and young adults are mainly affected. A large 
number of subclinical cases occur. Onset is abrupt and patients 
present with rigors, seizures, involuntary movements like chorea, 
myoclonus and tics, and hyperthermia. The mortality rate ranges 
from 20%- 40%.  The diagnosis can be confirmed if there is a 
fourfold increase of antibody titres between acute and convalescent 
sera or CSF. Viral culture is usually not successful.  
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Herpes Simplex Virus-2 meningitis is a major cause of 
meningitis in adults. About 25% of patients with acute genital herpes 
develop transient symptoms and signs of viral meningitis
 [3]
. The 
virus may invade the sacral spinal cord resulting in bladder and 
bowel disturbances. Transverse myelitis is a rare complication of 
HSV-2 infection. HSV is thought to be the commonest cause of 
Mollaret’s meningitis. 
Varicella-Zoster Virus (VZV) causes Varicella in children and 
herpes zoster in adults and one of the neurological complications is 
meningoencephalitis. The other complications are self-limiting 
cerebellar ataxia, transverse myelitis and Reye’s syndrome. 
HIV meningitis may be associated with cauda equina neuritis. 
A mononucleosis type of infection (fever, rash, arthralgia, and 
lymphadenopathy) may occur at the time of seroconversion from 
recent HIV infection. This is associated with acute, self-limited 
aseptic meningitis. Aside from viral isolation and serologic tests and 
more recently, detection by polymerase chain reaction, few 
laboratory examinations are helpful. 
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Mumps meningitis occurs sporadically throughout the year, 
but the highest incidence is in late winter and spring
 [3]
. Males are 
affected three times more frequently than females. Other 
manifestations of mumps infection- parotitis, orchitis, mastitis, 
oophoritis and pancreatitis- may be present. A definite past history 
of mumps aids in excluding the disease, as an attack confers lifelong 
immunity. Diagnosis is made by positive CSF viral culture or by 
detecting CSF IgM antibodies. 
Treatment: 
Treatment of almost all cases of viral meningitis is primarily 
symptomatic and includes the use of antipyretics, analgesics, and 
antiemetics. Monitoring of fluid and electrolyte status is must. 
Hospitalisation may not be required in immunocompetent patients 
with no alteration of consciousness, no focal signs or symptoms and 
classic CSF profile. Inpatient care is required only in patients with 
altered sensorium, seizures and focal deficits. 
 Acyclovir may be used in HSV-1 and 2, EBV and VZV 
infection and HAART in HIV meningitis. Seriously ill patients 
should receive intravenous acyclovir which can be followed by an 
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oral drug such as acyclovir, famciclovir, or valacyclovir for a total 
course of 7- 14 days.  
An investigational drug, pleconaril, has been shown to be 
efficacious against infections caused by enterovirus
 [4]
. 
Prognosis: 
 In adults there is full recovery following viral meningitis. In 
infants and neonates, the outcome is less certain. Learning 
disabilities, hearing loss have been reported in some studies.                                                                                                                                             
                                                                                                
TUBERCULOUS MENINGITIS: 
 Tuberculous meningitis is the commonest form of 
neurotuberculosis, accounting for 70-80% of cases
 [3]
. 
Neurotuberculosis can affect the meninges, brain, or spinal cord 
either individually or in various combinations. Of these tuberculous 
meningitis presents as subacute or chronic meningitis.  
Other organisms that can cause subacute meningitis include 
Cryptococcus neoformans, Histoplasma Capsulatum, Coccidiodes 
immitis and Trepenoma pallidum
 [4]
. 
 36 
Chronic meningitis is most commonly diagnosed when a 
characteristic neurologic syndrome exists for >4 weeks and is 
associated with a persistent inflammatory response in the CSF
 [4]
. 
In most western countries, the incidence of tuberculous 
meningitis, which parallels the frequency of systemic tuberculosis, 
has, until recently, decreased steadily. Since 1985 there has been a 
moderate increase in the incidence of systemic tuberculosis and 
tuberculous meningitis as a consequence of the HIV epidemic
 [2, 3]
. In 
fact, tuberculosis may be the first clinical manifestation of HIV 
infection. In India also, the incidence of TBM reflects the incidence 
of tuberculosis in general, comprising about 10% of all cases of 
tuberculosis
 [3]
. 
Etiology: 
 Tuberculosis of the nervous system is caused by the human 
strain of Mycobacterium tuberculosis. However, in 
immunocompromised persons, atypical mycobacteria, now called 
non-tuberculous mycobacteria (NTM) are important causes of 
infection. The principal organisms are Mycobacterium avium and 
Mycobacterium intracellulare. 
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Pathogenesis: 
 Tubercle bacilli hematogenously spread from the lungs during 
the stage of primary complex formation and settle in different areas 
of the CNS to form millet seed- sized (miliary) tubercles in the brain 
parenchyma
 [3]
. These small subarachnoid or subependymal tubercles 
are called the Rich’s foci. The highly vascular choroid plexus forms 
a common site for tubercle formation. Subsequent behaviour of each 
focus is individualised in the same person, one focus may progress 
while another just adjacent to it may remain static for years or 
regress. Some tubercles enlarge and begin to caseate. One or more of 
the tubercles may later rupture resulting in discharge of M. 
tuberculosis into the subarachnoid space. Since the choroid floats in 
the ventricular CSF where there is no supporting structure for the 
enlarging tubercle, this is the common site of rupture of a tubercle. 
Factors determining the development of meningitis include the 
number and virulence of the bacilli and the immune response of the 
host. 
 The immune response launched by the host is cellular rather 
than humoral. Macrophages ingest mycobacteria and destroy some 
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of them. The macrophages secrete cytokines, including TNF, which 
are thought to be responsible for the systemic manifestation of 
tuberculosis. The cell-mediated immunity (CMI) is usually 
beneficial to the host. However, the same immune response may 
give rise to the detrimental delayed type hypersensitivity (DTH) 
which results in host tissue damage in the CNS. 
Pathology: 
Meningeal Exudate: 
 The brunt of the pathologic process falls on the basal 
meninges, where a thick gelatinous exudate accumulates, 
obliterating the pontine and interpeducular cisterns and extending to 
the meninges around the medulla, the floor of the third ventricle and 
subthalamic region, the optic chiasm, and the undersurfaces of the 
temporal lobes. Cranial nerves are often involved by the 
inflammatory exudate as they traverse the subarachnoid space, 
indeed, far more often than with typical bacterial meningitis. 
Arteries may become inflamed and occluded, especially large 
vessels in the circle of Willis, and middle cerebral artery in the 
sylvian fissure, with infarction of brain. Histologically, the exudate 
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is serofibrinous. With treatment the exudate becomes fibrous, 
blocking the basal cisterns to cause hydrocephalus. 
Meningoencephalitis: 
 Unlike the typical bacterial meningitides, the disease process 
is not confined to the subarachnoid space but frequently penetrates 
the pia and ependyma and invades the underlying brain, so that the 
process is truly a meningoencephalitis. 
Hydrocephalus: 
 It is mostly of the communicating variety. Blockage of the 
basal cisterns in the interpeduncular fossa and the brainstem by 
exudate or granulation tissue is primarily responsible. 
Vasculopathy: 
 The dense basal exudates, which surround large and small 
arteries including the lenticulostriate, cause a vasculopathy leading 
to occlusion of vessels. It results in focal and diffuse ischemic 
changes in the brain and also large infarcts. Recently, there is 
increasing identification of young persons with stroke, resulting 
solely from tubercular vasculitis, without associated meningitis. The 
belief is that the presence of tubercular antigen in the vessel wall 
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induces an immunologic phenomenon of vasculitis, which leads to 
infarction manifesting as stroke. 
Tuberculoma Formation: 
 If a tubercle situated in the brain parenchyma starts 
progressing, it grows at the expense of the brain, which gets 
liquefied by the caseating process. The initial lesion is solitary or a 
cluster of microscopic foci, generally in the cortical or subcortical 
regions, consisting of a central area of necrosis surrounded by 
characteristic epitheloid and giant cell reaction. The site of 
tuberculoma is commonly the cerebellum in children and the 
cerebral hemispheres in adults. A fully formed tuberculoma has a 
creamy, white, gritty, caseating centre with crenated margins, 
surrounded by a firm to hard greyish rim of varying colour 
(pseudocapsule) of granulation tissue and compressed gliotic brain 
matter. 
Spinal meningitis: 
 Spinal meningitis though often asymptomatic is usually 
present with cranial meningitis. Most cases are an extension of the 
tuberculous basal exudate downwards. 
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Clinical Features: 
 The classical form of the disease evolves through a prodromal 
stage, a stage of meningeal irritation, leading to a stage of diffuse or 
focal cerebral involvement.  The onset is insidious, characterised by 
a vague illness lasting one or three weeks before meningeal 
symptoms and signs appear. Listlessness, apathy, irritability, lack of 
appetite, nausea, vomiting and abdominal pain are common features. 
Fever is of low grade or sometimes goes unnoticed. When 
meningeal irritation sets in, headache and vomiting becomes more 
prominent and neck rigidity and Kernig’s sign are found.  
In adults, the onset is frequently dominated by psycho 
behavioural manifestations. Focal or generalised epileptic fits may 
herald the onset in children. Abrupt onset of focal neurological 
deficit as the presenting feature is equally seen in both children and 
adults. Thus sudden onset of hemiparesis or monoparesis during the 
course of TBM is commonly recognised. The other modes of 
presentation of TBM include painful ophthalmoplegia, visual failure 
due to optochiasmatic arachnoiditis and other isolated cranial 
neuropathies. 
 42 
 As an assessment of severity of disease and a guide to 
prognosis, it is useful to stage patients clinically at the time of 
diagnosis, based on the British Medical Research Council 
classification. 
Stage 1 (Early Disease) 
 Patient has meningeal signs only, consciousness is 
undisturbed, and no focal neurological signs are present. 
Stage 2 (Medium severity) 
 Consciousness is disturbed but the patient is not comatose or 
delirious. Focal neurological signs and cranial nerve palsies may be 
present. These include hemiparesis, cranial neuropathies (II, III, IV, 
VI, VII, and VIII) and involuntary movements. Raised intracranial 
pressure may occur secondary to hydrocephalus. 
Stage 3 (Advanced Disease) 
 The patient is deeply comatose with evidence of brainstem 
dysfunction, decerebrate or decorticate posturing, fixed dilated 
pupils, irregular pulse and respiration. Untreated patients progress 
through the three stages and usually die. 
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 Cranial nerve palsies are seen in upto one-third of patients
 [3]
. 
Papilloedema is common, usually without visual impairment. When 
visual impairment is noticed, the possibilities are optochiasmatic 
arachnoiditis, tuberculoma compressing the optic nerve or 
ethambutol toxicity. Oculomotor and abducens nerve palsies (III and 
IV) are common, whereas VII and VIII cranial nerve affection is less 
frequent. Rarely internuclear ophthalmoplegia and horizontal gaze 
paresis may be seen. This indicates intrinsic brainstem dysfunction 
and a poor prognosis, possibly because adjacent vital structures are 
involved. The finding of choroid tubercles on fundoscopy is very 
helpful in diagnosis. 
 The incidence of focal neurological deficit, monoplegia, 
hemiplegia and aphasia is reported to vary from 10-45 percent. 
Epileptic seizures may present at any stage. They are more frequent 
in children than adults and are usually the direct effect of meningeal 
inflammation on the cerebral cortex. When increasing drowsiness or 
seizures appear during treatment, it is mandatory to ascertain the 
exact cause, as cerebral edema, obstructive hydrocephalus, 
expanding intracranial tuberculoma and hyponatremia due to 
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inappropriate antidiuretic hormone (ADH) secretion must all be 
considered and managed appropriately. 
 Patients with TBM may have multiple intracranial 
tuberculomas. They may appear at a time when meningitis is 
resolving. In adults, supratentorial lesions are more frequent.  
Tuberculomas behave like a slow growing tumour. Located in 
cerebral hemisphere, it may cause focal seizures, progressive 
hemiparesis, speech disturbance and disturbance of cognitive 
function. A history of active tuberculosis elsewhere in the body or 
contact with an infective case is given by 25-30% of patients.    
Spinal meningitis: 
 Tuberculous involvement of the spinal meninges may be either 
primary or secondary. Secondary spinal meningitis is commonly due 
to a spread of intracranial infection. It is reported in 10-30% of cases 
of TBM either during the course of its treatment or even years after 
the arrest of the disease. An uncommon source of secondary spinal 
meningitis is in association with tuberculous caries of the spine. 
Primary spinal meningitis consists of a rapid or slow, single or 
multiple level, ascending or transverse radiculomyelopathy. The 
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symptoms include fever, pain over the spine, root pains, paralysis, 
paraesthesiae, bladder disturbances and wasting of muscles. The 
disease may present in subacute or chronic forms. The clinical 
picture of the secondary spinal meningitis is initially dominated by 
the primary condition i.e. the cranial tuberculous meningitis. 
Symptoms and signs of spinal roots and cord (radiculomyelopathy) 
may supervene even while the intracranial lesion appears to be 
responding to therapy. 
Investigations: 
 The key investigations include cerebrospinal fluid examination 
and neuroimaging. 
Cerebrospinal Fluid Examination: 
Cytology: 
 The typical CSF picture of TBM is clear fluid under raised 
pressure, with elevated levels of protein and cells, and low glucose 
levels. The clear or slightly turbid fluid may form a pellicle or 
cobweb clot on standing. Cobweb formation is not specific and 
should not be considered diagnostic. The cell count is raised (100- 
500 cells/mm
3
). Characteristically, lymphocytes predominate in the 
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CSF. However, polymorphonuclear leucocytes may predominate 
early in the infection particularly during the first 10 days. This is 
transient, being replaced subsequently by a lymphocytic response. 
At times an initial mononuclear pleocytosis may change to a 
polymorphonuclear response upon initiation of treatment. This may 
be combined with a deteriorating clinical state, and it has been 
referred to as a therapeutic paradox
 [3]
. The CSF protein is usually 
between 100-500 mg/dL. It may reach 1 gm/dL in patients with 
spinal block. The CSF glucose is less than 40 mg/dL in 50-85% of 
patients. An increase in CSF glucose with antituberculous therapy 
strengthens the diagnosis and indicates a better prognosis. 
Microbiology: 
 Demonstration of tubercle bacilli in smear or culture is the 
only sure method of establishing the diagnosis of TBM. Most 
investigations reported from India achieve a positivity rate of only 
about 15-20%
 [3]
. Detection rate may be increased by centrifuging 
10- 20 ml of CSF for 30 minutes, preparing a thick smear from the 
deposit and examining it for up to 90 mins. It is believed that 
staining the cobweb may increase the probability of finding AFB. 
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Success with this traditional identification of tubercle bacilli in 
smears of CSF sediment stained by Ziehl-Neelson method is a 
function not only of their number but also of the persistence with 
which they are sought. 
 It takes several weeks (4 to 8 weeks) to obtain positive culture 
results in the conventional Lowenstein- Jensen (L-J) medium and the 
positivity is ~50% in adults
[2, 3]
. Culture remains the gold standard to 
make the diagnosis of TBM. Contemporary systems such as 
radiometric BACTEC and biphasic (Roche SeptiChek) culture 
improve the speed of mycobacterial recovery by 7- 10 days
 [2, 3]
. But 
even with these methods, deferral of treatment to await results (2- 4 
weeks in smear negative cases) is impractical.  In order to overcome 
the difficulties encountered in isolating the organism, numerous tests 
have been devised over the last few years. 
 These tests can be broadly classified into two groups
 [2]
: 
Indirect tests which measure the host response to the organism: 
 These include the estimation of the adenosine deaminase level 
in CSF, the bromide partition test, and measurement of antibody to 
AFB in the CSF. Adenosine deaminase, an enzyme produced by T-
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lymphocytes, is elevated in the CSF of 60-100% of patients with 
TBM
 [3, 7, 13, 19, and 37]
. The bromide partition test measures the ratio of 
serum to CSF bromide after a loading dose. A ratio of less than 0.6 
is said to be characteristic of TBM, but it is not routinely used as it is 
falsely positive in other forms of meningitis
 [3]
.  
Serological tests are used to detect antibodies against 
mycobacterial antigens. Several antigens that have been evaluated 
include antigen 5, plasma membrane antigen, A60 antigen and 
glycolipids. These serological tests have been well studied in smear 
positive pulmonary tuberculosis, but the utility of these tests in TBM 
remains uncertain.  
Direct tests which identify chemical components or antigens of the 
bacilli themselves: 
These are the estimation of CSF tuberculostearic acid by gas 
chromatography or mass spectroscopy, the CSF 3-2’-ketohexyl 
indoline estimation, the identification of M. tuberculosis antigen in 
CSF by ELISA or RIA and the detection of M. tuberculosis DNA by 
PCR. 
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PCR: 
 PCR by DNA amplification permits the detection of small 
amounts of tubercle bacilli and now is widely available for clinical 
use. Some of the targets used in tuberculosis are IS6110 DNA 
sequence, 65KDa gene and MPB65 gene
 [3]
. Nested PCR is a 
recently introduced technique whereby both sensitivity and 
specificity may be increased. PCR for M. tuberculosis is not affected 
by the presence of other infecting bacteria as may occur in an 
immunocompromised host. But the cost of PCR and sophisticated 
lab for the procedure precludes its use in developing countries. 
Imaging: 
 Contrast CT scan and gadolinium enhanced MRI are very 
useful in the diagnosis of CNS tuberculosis and in assessing its 
complications. They are quite helpful in patients who develop raised 
intracranial pressure, hydrocephalus, or focal neurologic deficits. 
Tuberculomas can be visualised. MR or CT angiography may 
demonstrate vascular occlusive disease from granulomatous 
infiltration of the walls of arteries of the circle of Willis and their 
primary branches.   
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Hydrocephalus is the single most common abnormality and is 
reported in 50-80% of patients. The degree of hydrocephalus 
generally correlates with the duration of the disease. Enhancement of 
the basal meninges (60%), followed by cerebral infarction (28%), 
most frequently in the middle cerebral artery territory are other 
common findings. 
 In Spinal Meningitis, Myelography was the standard 
investigation for diagnosis as it yielded fairly specific images on 
radiography. Multiple filling defects, large areas of ‘candle 
guttering’, ‘bundle of faggot sticks’ appearance in the region of the 
cauda equina, arachnoid cysts, and blocked dye with a ‘frayed’ edge 
are some of the images vividly described. The T2 weighted MRI 
sequences of the spine show CSF loculation, obliteration of spinal 
subarachnoid space, loss of sharp outline of spinal cord in 
cervicothoracic region, clumping of nerve roots in lumbar region and 
nodular thick intradural enhancement after gadolinium injection.  
CNS Tuberculosis and HIV infection: 
 Cognitive deficit is more commonly seen in HIV-positive 
patients. In these patients CT scan shows lesser meningeal 
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enhancement and communicating hydrocephalus than in those 
without HIV infection. Granulomatous exudate in the basal cisterns 
is less remarkable in the brain of HIV-infected patients. 
Periventricular and white matter infarcts are commonly seen. But 
changes of occlusive arteries in the basal cisternal vessels are 
uncommon. 
Management of TBM: 
 The most important factor in preventing death and permanent 
neurological sequelae in patients with TBM is early initiation of 
treatment even if the diagnosis is not fully confirmed, as often 
happens. 
Anti-Tuberculous Drugs: 
 Treatment is usually started with combination of Isoniazid 
(300mg/day), rifampicin (10mg/kg per day), pyrazinamide (30 
mg/kg per day in divided doses), ethambutol (15-25 mg/kg per day 
in divided doses) and pyridoxine (50mg/day). 
 The primary goal of antituberculous chemotherapy is to kill 
tubercle bacilli rapidly, prevent the emergence of drug resistance and 
eliminate persistent bacilli from the host tissues to prevent relapse.  
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 Isoniazid is the most powerful drug used in the treatment of 
tuberculosis, being responsible for killing the great majority of 
rapidly dividing bacilli. Because of its very good CSF penetration 
irrespective of meningeal inflammation, the efficacy of this drug is 
readily understandable. 
 Rifampicin’s contribution to the treatment of TBM is 
relatively modest and significantly less than that in pulmonary 
disease.  
Pyrazinamide has good oral absorption, excellent CSF 
penetration and sterilizing effect on the tubercle bacilli and this has 
resulted in mandatory inclusion of this drug in the intensive phase 
for the initial 2-3 months. Given the uncertain benefit and 
penetration of rifampicin, pyrazinamide should be given for the full 
duration of antitubercular therapy.  
The total duration of treatment is not based on any firm control 
data but it has been customary to use long courses of treatment (18 
months to two years)
 [3]
. But studies have demonstrated that six 
months, nine months and one year regimens may be equally 
effective. An Indian study however considers short courses to be 
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inadequate and associated with increased relapse rate. Current UK 
guidelines recommend 12 months of ATT in uncomplicated cases of 
TBM extending to 18 months if pyrazinamide is omitted. 
Dexamethasone therapy is recommended for HIV-negative patients 
with tuberculous meningitis. The dose is 12–16 mg per day for 3 
weeks, and then tapered over 3 weeks. Administration of steroids is 
found to be most beneficial when complications like raised 
intracranial pressure, cerebral oedema, stupor, focal neurological 
signs, spinal block, hydrocephalus and basal optochiasmatic 
arachnoiditis appear. 
Surgical Intervention: 
 The most important role of surgery is the prompt reduction of 
obstructive hydrocephalus by a ventriculo-peritoneal shunt. In the 
case of tuberculoma, surgical excision is indicated when the anterior 
optic pathways are compressed with resultant visual impairment or 
for large tuberculomas with great rise of intracranial pressure not 
permitting time for effective medical therapy. In spinal meningitis, 
surgery has no role.  
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Prognosis: 
 The change in therapy over the years has not been reflected by 
improved prognosis. Despite therapeutic advances, the most 
important prognostic factors are still the stage of disease when the 
treatment is commenced, and the patient’s age. Children under three 
years and adults over 65 years have a significantly worse prognosis. 
If treatment is started in stage 1 of TBM, almost all patients survive 
with little or no neurological deficit, whereas 50% of those first 
treated in stage 3 die, and those who recover may have permanent 
deficits. These sequelae are more common in children and include 
mental retardation, behavioural changes, seizures, visual or auditory 
loss, movement disorder, hemi/para/quadriplegia and various 
endocrinopathies due to hypothalamic- pituitary damage. Infection 
with HIV does not alter the prognosis of TBM, except that patients 
with CD4 count <0.2 * 10
9
/L have a significantly reduced chance of 
survival. Failure to diagnose spinal meningitis and treat it early 
results in permanent disability. 
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Prevention: 
 The reported efficacy of BCG vaccine in preventing 
pulmonary tuberculosis varies from 0 to 80%. However its efficacy 
in preventing tuberculous meningitis ranges from 52 to 84 percent.  
ADENOSINE DEAMINASE: 
Adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) 
or ADA is an enzyme involved in purine metabolism and it has been 
found in most mammalian tissues. A single genetic locus on 
chromosome 20 primarily controls ADA in man (Hirschhorn, 1975)
 
[20]
. Interest in this enzyme has been revived by the association 
between combined immunodeficiency and ADA deficiency 
(Meuwissen & Pollara, 1974) and further stimulated by the finding 
of a deficiency of the metabolically related enzyme nucleoside 
phosphorylase in a child with defective T-cell function (Giblett et 
al., 1975).  
ADA catalyses the irreversible deamination of 
2΄deoxyadenosine and adenosine to deoxyinosine and inosine. 
Research of the 1980s increased the use of adenosine deaminase as a 
diagnostic tool in a variety of illnesses including meningitis and 
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tuberculosis. Two different isozymes have been identified- ADA1 
and ADA2. ADA1 deficiency results in immunodeficiency and it is 
a Zn binding protein. ADA2 is produced by monocytes. The 
sequence of the enzyme is highly conserved from bacteria to 
humans. Adenosine deaminase has a (beta/alpha)8 barrel structural 
motif, and contains a zinc atom in the catalytic pocket. Zinc or 
cobalt is necessary for catalytic activity. 
ADA helps to detect or rule out Mycobacterium 
tuberculosis infection in pleural fluid in order to assist in the 
diagnosis of tuberculosis 
[14]
; also to detect the infection in other 
body fluids such as peritoneal fluid or cerebrospinal fluid (CSF). 
ADA estimation in ascitic fluid at cut-off level of 30-32U/L has been 
found to be highly useful in diagnosis of tuberculosis
 [3]
. In pleural 
fluid the cut –off is around 70 U/L [14]. In CSF, various cut-offs have 
been studied from 5-15U/L
 [7, 8, 15, 17, 21, 22]
. ADA is mainly produced 
by immature T cells. ADA may be considered as an indicator of 
activation of cell mediated immunity. Its level is high in tuberculous 
pleural effusion, peritonitis and meningitis. A significant rise in 
levels of enzyme was observed during the first 10 days of therapy of 
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TBM, was followed by a gradual decline, and reached normal values 
after three to four months of treatment. 
Moreover, estimation of ADA can be done by a simple 
method. Quantification is done spectrophotometrically as ADA 
catalyses the conversion of adenosine, resulting in liberation of 
ammonia, which produces a coloured indophenol compound
 [5]
. 
Compared to other complex tests, the advantages of this test are 
1. Feasibility of doing this test in simple labs by ordinary 
methods. 
2. Early availability of results within 4-6 hrs. 
Studies Demonstrating the Usefulness of CSF ADA in 
Differentiating Various Types of Meningitis: 
Rajendra Prasad Et Al Conducted a Study in K.G’s Medical 
College, Lucknow (U.P). In This Study Adenosine deaminase 
activity (ADA) was studied in cerebrospinal fluid of 29 cases of 
tuberculous meningitis, 15 cases of pyogenic meningitis, 12 cases of 
aseptic meningitis and 20 controls (patients without any neurological 
disorders who were given spinal anaesthesia). The mean 
cerebrospinal fluid adenosine deaminase activity was respectively 
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6.43 ± 1.93; 1.89 ± 0.91; 0.90 + 0.45 and 0.64 ± 0.57 IU/L in 
tuberculous meningitis, pyogenic meningitis, aseptic meningitis and 
controls. The adenosine deaminase activity in tuberculous meningitis 
cases was significantly higher
 [16]
. The sensitivity and specificity of 
this test for diagnosis of tuberculous meningitis was 100% and 
97.87% respectively with ADA value of more than 3.30 IU/L. Thus, 
adenosine deaminase activity in CSF, a relatively inexpensive and 
easy procedure, can be of great value in the diagnosis of tuberculous 
meningitis. 
In the study conducted by Satya Vati Rana, Raj Kumar 
Singhal, Kartar Singh & Lata Kumar in Department of Paediatrics 
and Gastroenterology, Postgraduate Institute of Medical Education 
and Research, Chandigarh, Adenosine deaminase activity (ADA) 
was estimated in cerebrospinal fluid (CSF) of 30 patients of 
tuberculous meningitis (TBM) and 10 patients each of partially 
treated pyomeningitis (PTM), aseptic meningitis (AM) and pyogenic 
meningitis (PM)
 [18]
. Mean ADA levels in CSF of TBM patients were 
higher (18.22 U/L) as compared to 6.28 U/L, 3.43 U/L and 7.98 U/L 
in PTM, AM and PM respectively. This difference of ADA values in 
CSF between TBM and other types of meningitis was statistically 
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significant (p<0.01) different. Sensitivity and specificity of ADA 
levels in CSF of children to diagnose tuberculous meningitis was 
66.6% and 90% respectively at 10 U/L cut off of ADA levels in 
CSF. ADA levels in CSF could also differentiate PTM, AM and PM 
from TBM with a specificity of 90%, 100% and 80% respectively. 
Gupta et al observed that adenosine deaminase levels in 
nontuberculous disease rarely exceeded the cut-off; set for 
tuberculous disease. They have further observed that ADA 
estimation is not only a fairly sensitive and specific test (more than 
90 %), helpful in differentiating tubercular from non-tubercular 
etiology
 [14]
; both in pulmonary and extra-pulmonary disease but is 
also simple, inexpensive and rapid. For this reason this test may help 
in early diagnosis, improve the prognosis and reduce spread of 
disease and sequelae. 
Rajesh baheti, Purnima Laddha, RS Gehlot of Dr. SN Medical 
College, Jodhpur conducted a study in 38 patients of meningitis of 
varied etiology. Diagnosis was established by relevant investigations 
and patients were divided in different groups. CSF - ADA estimation 
was done by using spectrophotometer. The range of ADA was 6.2 to 
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21.8 (IU/L) in TBM with a mean of 12.23 (IU/L), while a range 
between 1.6 - 5.6 (IU/L) with a mean of 4.37 (IU/L) was noted with 
pyogenic meningitis. Similarly, ADA levels between 1.11 - 8.3 
(IU/L) with 3.32 (IU/L) mean were observed with aseptic 
meningitis; whereas a range of 0.33 to 2.8 (IU/L) with a mean of 
1.37 observed in control group
 [11]
.  CSF-ADA level 6.5 IU/L as a 
cut-off value exhibited 95.83% sensitivity and 92.85% specificity in 
differentiating tuberculous from non-tuberculous meningitis. 
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AIMS AND OBJECTIVES 
 
1. To estimate the level of CSF Adenosine Deaminase in different 
types of meningitis & 
2. To assess its usefulness in differentiating the various types 
(bacterial, viral and tuberculous) of meningitis. 
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MATERIALS AND METHODS 
The study was conducted at the medical wards of Govt Rajaji 
Hospital, Madurai. 
Design of Study  :  Prospective Analytical study 
Period of Study :   April 2012 to September 2012 
Ethical committee approval:  
Institutional Ethical Committee (IEC) of Madurai Medical 
College and Govt. Rajaji Hospital approved this research. 
Collaborating departments:  
           General medicine, Neurology, Biochemistry, Microbiology. 
Study Population:   
Patients presenting with features suggestive of meningitis were 
the study subjects.  
The diagnosis of meningitis was made on the basis of clinical 
symptoms and signs like headache, fever, nausea, vomiting, neck 
rigidity, presence of Kernig’s and/or Brudzinski’s sign, altered 
sensorium, any focal neurological deficit, cranial nerve palsies, 
seizures and/or signs of cerebral dysfunction ranging from 
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confusion, delirium, declining level of sensorium from lethargy to 
coma. 
 50 Consecutive medical ward in-patients of GRH who had 
meningitis were prospectively enrolled and included in the study 
after informed consent.  
Inclusion criteria: 
 Age > 12 years. 
 Patients with features of meningitis. 
Exclusion criteria: 
 Age <12 years. 
Patients in whom lumbar puncture was contraindicated like 
- Those with coagulopathy ( Partial Thromboplastin Time > 50, 
international normalised ratio> 1.4, platelet count <1,00,000/mm
3
) 
- Those with local skin reactions and known spinal cord tumours. 
Diagnostic classification of the subjects: 
 The different types of meningitis patients were separated on 
the basis of CSF cytochemistry and clinical features. 
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 Tuberculous meningitis was confirmed if CSF culture 
yielded M. tuberculosis or a positive Ziehl - Neelson stain. Probable 
disease was diagnosed in the presence of a lymphocytic pleocytosis 
in the CSF with high protein content and low glucose content, 
negative bacterial and fungal cultures.  
 Acute bacterial meningitis was diagnosed in patients with 
CSF neutrophilia, high protein content, low glucose content and a 
positive gram stain and bacterial culture.  
 Viral meningitis was diagnosed if there was predominantly 
lymphocytic pleocytosis in the CSF with a normal or mildly raised 
protein content, a normal glucose content and negative bacterial, 
fungal and mycobacterial cultures.  
Clinical and Laboratory Data:  
  History, clinical examination and laboratory investigation 
were carried out in all patients and details recorded in a predesigned 
proforma. Important clinical details regarding duration of fever, 
signs of meningeal irritation, focal neurological deficits and cranial 
nerve palsies were elicited. Laboratory examination included CSF 
analysis (appearance, cell counts, biochemistry, Gram, AFB & India 
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ink stain), blood counts, blood culture & sensitivity, Mantoux test, 
HIV test.  Based on clinical and laboratory data, patient’s type of 
meningitis was confirmed and treatment started accordingly. 
Collection of CSF sample: 
This was done by lumbar puncture. Colour and cobweb 
formation was noted.  Total and differential cell count was 
estimated. Biochemical analysis of protein, sugar, chloride and 
globulin was done. Microbiological workup of the sample was done 
to find out the etiological organism with the help of Gram’s, Ziehl- 
Neelson and Indian ink stains. About 2 ml of CSF was used to find 
out the ADA level.  
 Estimation of CSF ADA: 
CSF Adenosine deaminase level was measured at 37°C 
according to the method of Guisti and Galanti based on the Berthlot 
reaction that is the formation of coloured indophenol complex from 
ammonia liberated from adenosine and quantified 
spectrophotometrically
 [5]
. One unit of ADA is defined as the amount 
of enzyme required to release 1 mmol of ammonia/min from 
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adenosine at standard assay conditions. Results were expressed as 
units per litre per minute (U/L/min).  
Assessment of outcome:  
  The primary outcome studied was the CSF ADA level in 
various types of meningitis and comparison of the level of elevation 
in tuberculous with other types of meningitis. 
Statistical Analysis: 
  Descriptive statistical analysis was carried out in the study. 
Sigma Stat statistical software was used in the study. Microsoft word 
and Excel were used to generate graphs, tables etc. The CSF ADA 
mean values were calculated for the different meningitis category 
patients. One-way Anova & Chi square tests were used to determine 
statistical significance. Sensitivity, specificity, PPV, and NPV were 
calculated to know the diagnostic performance of ADA levels in 
relation to type of meningitis. 
 
 
 
 67 
OBSERVATIONS AND RESULTS 
Table 1- Age Distribution of Meningitis 
Age in 
years 
No. of cases TBM BM VM 
<20 11 2 5 4 
21-40 19 12 3 4 
41-60 16 9 4 3 
>60 4 1 1 2 
Total 50 24 13 13 
Age Distribution of Meningitis
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3
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e
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TBM BM VM
 
Tuberculous meningitis occurred more in the age group of 21 
– 40 years. Bacterial meningitis was seen mainly in patients < 20 
years of age. Viral meningitis was seen in all age groups 
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Table 2- Sex Distribution of Meningitis 
Sex No. of 
cases 
TBM BM VM 
Male 33 16 9 8 
Female 17 8 4 5 
Total 50 24 13 13 
Sex Distribution
16
9
88
4
5
0
2
4
6
8
10
12
14
16
18
TBM BM VM
Male Female 
 
Out of 50 cases, 33 were males. All three types of meningitis 
(tuberculous, bacterial and viral meningitis) were more common in 
males. 
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Table 3- Distribution of types of Meningitis 
Type of Meningitis No. of cases % of cases 
BM 13 26 
TBM 24 48 
VM 13 26 
Total 50 100 
13
26
24
48
13
26
0
5
10
15
20
25
30
35
40
45
50
BM TBM VM
Type of Meningitis
No.of cases Percentage
 
Of the 50 cases, 24 had tuberculous meningitis. Viral and 
bacterial meningitis constituted 13 cases each. The percentages of 
tuberculous, bacterial and viral meningitis were 48%, 26% and 26% 
respectively. 
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Table 4- Mean CSF ADA level in various types of Meningitis 
Type of Meningitis Mean CSF ADA Level (U/L) 
BM 4.54 
TBM 24.5 
VM 2.65 
4.54
24.5
2.65
0
5
10
15
20
25
BM TBM VM
Mean CSF ADA in  Meningitis (U/L)
Mean ADA
 
CSF ADA level was highest in tuberculous meningitis, the 
mean value being 24.5 U/L. The mean value of ADA in bacterial 
meningitis was 4.54 U/L and viral meningitis patients had lowest 
mean ADA value of 2.65 U/L. 
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Table 5- Distribution of Meningitis with respect to CSF ADA cut 
off level-10 U/L 
 
CSF ADA 
Level (U/L) 
No. of cases BM TBM VM 
<10 28 13 2 13 
>10 22 - 22 - 
Total 50 13 24 13 
 
13
2
13
0
22
0
0
5
10
15
20
25
<10 >10
Distribution of Meningitis with regard to CSF ADA cut off of 10U/L
BM TBM VM
 
 
 
Of the 50 patients, 28 had ADA <10 U/L. Out of this, 26 cases 
belonged to the viral and bacterial meningitis groups and the rest 2 
had tuberculous meningitis. About 22 patients had CSF ADA >10 
U/L and all of them belonged to tuberculous meningitis group. 
 
 72 
Table 6- Diagnostic Performance of CSF ADA (at 10 U/L cut off) 
in relation to the type of Meningitis 
 Test (CSF ADA )   
Disease >10 <10 Total 
TBM 22 (a) 2 (c) 24 (a+c) 
NonTBM 
(BM&VM) 
0 (b) 26 (d) 26 (b+d) 
Total 22 (a+b) 28 (c+d) 50 
P value      = < 0.001 (statistically significant) 
Sensitivity =  22/22 * 100 = 100% 
Specificity  =  26/28 * 100 = 92.85% 
Positive Predictive Value = 22/24 * 100 = 91.66% 
Negative Predictive Value = 26/26 * 100 = 100%. 
22
0
2
26
0
5
10
15
20
25
30
>10 <10
Diagnostic performance of CSF ADA in relation to TBM
TBM           (24) Non TBM (26)
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Table 7- CSF Protein level according to the type of Meningitis 
 
CSF Protein 
(mg/dL) 
No. of 
cases 
TBM BM VM 
<40 11 0 1 10 
40 - 80 24 11 10 3 
80 - 120 10 8 2 0 
>120 5 5 0 0 
Total 50 24 13 13 
CSF Protein in various types of Meningitis
0
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     Of the TBM patients, majority had CSF protein level more than 
80 mg/dL. Most of the viral meningitis patients had protein level less 
than 40 mg/dL. Among the bacterial meningitis patients, protein 
level was found to be between 40 – 80 mg/dL predominantly. 
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Table 8-CSF cell count analysis according to the type of 
meningitis 
CSF cell 
count 
(cells/μL) 
No. of 
cases 
TBM BM VM 
<50 28 14 1 13 
50 -100 6 6 0 0 
100 – 200 10 3 7 0 
>200 6 1 5 0 
Total 50 24 13 13 
CSF  Cell Count
14
6
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13
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2
4
6
8
10
12
14
16
< 50 50 – 100 100 – 200 > 200
TBM BM VM
 
In TBM group, 14 patients had cell count less than 50 cells/μL 
and 10 patients had cell count more than 50 cells/μL. Most of the 
bacterial meningitis patients had cell count more than 100 cells/μL. 
All the viral meningitis patients had cell count less than 50 cells/μL. 
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Table 9- CSF sugar level according to the type of Meningitis 
CSF Sugar 
(mg/dl) 
No. of 
cases 
TBM BM VM 
<40 29 17 12 0 
>40 21 7 1 13 
Total 50 24 13 13 
CSF Sugar in relation to type of meningitis
17
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13
0
2
4
6
8
10
12
14
16
18
TBM BM VM
< 40 > 40
 
In tuberculous and bacterial meningitis group, majority had 
low sugar (<40 mg/dL). All the viral meningitis patients had normal 
CSF sugar. 
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Table 10- Mantoux status with regard to CSFADA level in 
Tuberculous Meningitis 
Mantoux/ CSF ADA <10 U/L >10 U/L 
Positive 2 12 
Negative 0 10 
Total 2 22 
2
0
12
10
0
2
4
6
8
10
12
< 10 > 10
Mantoux status & ADA level in TBM
(+) (-)
 
 
Of the 24 TBM patients, 14 had mantoux positivity and 10 
were mantoux negative. Of the 14 mantoux positive TBM patients, 
12 had ADA more than the cut off level i.e. more than 10 U/L. 
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Table 11- Presence of Focal Neurological Deficit in TBM 
Focal Neurological 
Deficit 
No. of cases % of cases 
Present 7 29.2 
Absent 17 70.8 
Total 24 100 
7
29.2
17
70.8
0
10
20
30
40
50
60
70
80
(+) (-)
Focal neurological deficit in TBM
No.of cases Percentage
 
Of the 24 TBM patients, 7 had developed focal neurological 
deficits and cranial nerve palsies.  Of these 7 patients, one had Right 
hemiparesis, one had left monoparesis, and one had paraparesis. 2 
patients had developed 3
rd
 cranial nerve palsy and another 2 had 
developed 6
th
 cranial nerve palsy. 
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Table 12- Extraneural TB (Pulmonary TB) in patients with 
TBM 
Extraneural TB No. of cases % of cases 
Present 7 29.2 
Absent 17 70.8 
Total 24 100 
 
7
29.2
17
70.8
0
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20
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40
50
60
70
80
+ -
Extraneural TB
No.of cases Percentage
 
Pulmonary TB was associated in 7 of the 24 TBM patients. 
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Table 13- CT/MRI Findings in patients with TBM 
CT/MRI Findings No. of cases % of cases 
BE 1 4.17 
ME 5 20.83 
BE & ME 2 8.33 
Normal 16 66.67 
Total 24 100 
1
4.17
2
8.33
5
20.83
16
66.67
0
10
20
30
40
50
60
70
BE BE, ME ME Normal 
CT / MRI Findings in TBM
No.of cases Percentage
 
 
Of the 24 patients with TBM, 8 had positive findings in 
neuroimaging in the form of basal exudates (4.17%), meningeal 
enhancement (20.83%) and both meningeal enhancement and basal 
exudates together in 8.33% patients. 
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DISCUSSION 
There is considerable urgency in establishing the correct 
diagnosis in patients with meningitis since specific therapy is most 
effective when instituted early in the course of illness. While waiting 
for cultures to confirm the diagnosis, irreversible brain damage can 
occur. Clinical features, CSF cytology, biochemistry and 
microbiology results are many a time inconclusive with regard to 
confirmation of diagnosis. So in suspected meningitis patients, 
specific treatment for tuberculous or non-tuberculous (bacterial or 
viral) etiology is usually begun on the basis of presumptive clinical 
diagnosis. 
Moreover in the diagnostic evaluation of meningitis, 
sophisticated methods are necessary which are not routinely 
available in government institutions in developing countries like 
ours. In this situation, CSF Adenosine deaminase (ADA) estimation 
which is simple, cost effective and rapid, helps in differentiating the 
etiology of meningitis when other findings are ambiguous. Hence 
this simple test aids in prompt and appropriate treatment of this 
medical emergency and helps in saving many lives. 
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A total of 50 clinically suspected cases of meningitis admitted 
in GRH, were studied. 50 cases comprised of tubercular meningitis-
24, bacterial meningitis-13 and viral meningitis-13 cases. CSF ADA 
activity was estimated in these patients. 
Adenosine deaminase level was clearly higher in patients with 
tuberculous meningitis in our study, consistent with various earlier 
studies
 [7, 8, 15, 17, 21, and 22]. 
By using 10 U/L as the cut off value, the test 
had sensitivity of 100% and specificity of 92.85% in identifying 
cases with tuberculous meningitis. The positive predictive value and 
the negative predictive value were 91.66% and 100% respectively. 
The higher level of ADA in tuberculous meningitis was statistically 
significant (p<0.001).   
In comparison to our study, Gupta et al in their study 
established that CSF ADA level of 10 U/ L as a cut off value 
exhibited 94.73 % sensitivity and 90.47% specificity in 
differentiating tuberculous from non-tuberculous meningitis. 
Various other studies used different cut off level for ADA, as 3.3 
U/L in the study by Rajendra Prasad et al with sensitivity of 100% 
and specificity of 97.87%, 6.5 U/L in the study done by Rajesh 
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Baheti with sensitivity of 95.83 % and specificity of 92.85% and 
15.5 U/L in the study by Verajit Chotmongkol in Thailand with 
sensitivity and specificity of 75% and 93% respectively. 
The mean ADA level in CSF in cases with tuberculous 
meningitis was 24.5 U/L. It is considerably higher than that reported 
by other workers (11.7- 15.7 U/L). The range of CSF ADA level in 
TBM in our study was 6.0 U/L to 84.3 U/L. 
The mean ADA level in CSF in bacterial meningitis and viral 
meningitis was 4.54 U/L and 2.65 U/L respectively. This is in 
comparison to the mean ADA level of bacterial meningitis 
(3.80±1.92 IU/L) and viral meningitis (1.85±1.43 IU/L) in the study 
done in Sri Siddhartha Medical College, Tumkur. 
Among the nontuberculous etiology, thus ADA level was 
helpful in differentiating between viral and bacterial meningitis.  
Age and Sex distribution of meningitis: 
 Most of the patients belonged to the 21-40 years age category 
followed by 41-60 years age group. Majority of the tuberculous 
meningitis patients belonged to the 21-40 years age group. Bacterial 
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meningitis patients were younger (<20 years). Viral meningitis 
occurred in all age groups. 
 There was a male predominance of patients in our study, male 
to female ratio of 1.9:1  
CSF Biochemistry Characteristics: 
Higher CSF protein levels were found in tuberculous and 
bacterial meningitis patients and 5 patients with TBM had CSF 
protein more than 120mg/dL and one had protein level of 
2600mg/dL. 
Higher CSF cell counts were found mainly in patients with 
bacterial meningitis and 5 of them had cell count more than 200 
cells/μL. 
Lower CSF sugar levels were found in both tuberculous and 
bacterial meningitis patients. 
Complications and associated characteristics of TBM: 
Focal neurological deficits and cranial nerve palsies were 
found in 7 TBM patients. Mantoux positivity in tuberculous 
meningitis was found in 14 cases out of 24 cases. Extraneural TB 
was found in 7 TBM patients in the form of pulmonary TB. In TBM 
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patients, positive CT/MRI findings were observed in 8 of the 24 
patients. 
2 patients in our study were HIV positive and they had 
developed tuberculous meningitis. HIV positivity did not affect the 
ADA level in these patients.  
In case of bacterial meningitis, gram stain positivity was found 
in 9 of the 13 cases. 
These were the other observations in our study apart from the 
CSF ADA characteristics.  
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CONCLUSION 
In our study, 50 patients with meningitis admitted in 
Government Rajaji Hospital from April 2012 to September 2012 
were evaluated. 
Meningitis predominantly affected people in the age group of 
20-40 years in our study with a male: female ratio of 1.9:1. 
Cases of tuberculous meningitis constituted 48% of the study 
group and bacterial and viral meningitis were 26% each. 
CSF protein values were higher and sugar values lower in 
patients with tuberculous and bacterial meningitis. CSF cell counts 
were higher in patients with bacterial meningitis. 
The conclusions that can be drawn from our study, regarding 
CSF Adenosine Deaminase (ADA) estimation are as follows: 
- CSF ADA is a simple, time saving, inexpensive indirect test that 
helps in identifying the type of meningitis, differentiating 
tuberculous from nontuberculous etiology. 
- Further among the nontuberculous group of meningitis, ADA values 
are lowest in viral meningitis and thus it can aid in distinguishing 
bacterial from viral etiology. 
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- CSF ADA estimation can be done at routine labs 
spectrophotometrically and assayed according to the method of 
Guisti. 
- CSF ADA cut-off of 10U/L considered in our study has 100% 
sensitivity and 92.85% specificity in differentiating tuberculous from 
nontuberculous etiology as early as possible, facilitating immediate 
management of these patients preventing morbidity and mortality 
due to delay in management. 
However, as the study was limited to a small population due to 
financial and laboratory constraints, analysis of a larger group would 
definitely give an insight into the further finer relationship between 
CSF ADA and clinical severity and outcome of meningitis patients. 
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CASE PROFORMA 
 
NAME  : 
AGE  : 
SEX  : 
 
CLINICAL PROFILE:  
Fever Duration 
Headache 
Photophobia 
Vomiting 
Altered Sensorium 
Signs of Meningeal Irritation 
Neck Stiffness 
Kernig’s Sign 
Brudzinski’s Sign 
Focal Neurological Deficits/ Cranial Nerve Palsies 
Features of Extraneural TB 
Past H/O of Pulmonary TB/ ATT Intake 
Contact H/O For TB 
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LAB: CSF:                                        BLOOD                  
 Colour      Hb   
 Presence of Cobweb    TC 
Protein       DC 
Sugar       ESR 
Chloride      VCTC 
Globulin             Culture & Sensitivity 
Cells, TC, DC     Mantoux test 
Gram Stain, AFB Stain  
Indian ink Stain 
Culture & Sensitivity  
ADA 
IMAGING:   
CHEST X RAY 
CECT/MRI 
Meningeal enhancement 
Basal exudates 
Tuberculoma 
 
TYPE OF MENINGITIS: 
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1 Gunasekaran 35 M 7 Days + + + + + 98 120 28 + 14.32 + ME NR - - - TBM 
2 Ulaganathan 50 M 14 
Days 
+ + + - - 10 100 32 + 20.1 - Normal NR - - - TBM 
3 Govindaraj 56 M 21 
Days 
+ + - + + 24 76 34 _ 28.4 + Normal NR - - - TBM 
4 Vellaimmal 35 F 6 
Months 
+ + - - - 110 250 19 + 21.3 - Normal NR - - - TBM 
5 Najima 42 F 24 
Days 
+ + + + + 40 2600 16 + 25 - ME NR - - - TBM 
6 Murugesan 30 M 15 
Days 
+ + - + + 40 110 40 + 25.3 - Normal NR - - - TBM 
7 Selvam 15 M 5 Days - - - - - 11 60 52 - 2.03 - Normal NR - - - VM 
8 Selvakumar 26 M 14 
Days 
+ - - - - 42 100 76 + 24.8 - Normal NR - - - TBM 
9 Chellapandi 13 M 4 Days + + + - - 800 96 20 + 2.5 - Normal NR + - - BM 
10 Kanagavel 56 M 10 
Days 
+ - - - - 60 66 31 + 15.8 + Normal NR - - - TBM 
11 Subbaiah 74 M 5 Days + - - - - 5 28 96 - 3 - Normal NR - - - VM 
12 Sivapandi 23 M 15 
Days 
+ + + - + 28 120 36 - 13 - ME NR - - - TBM 
13 Manikandan 48 M 3 Days - - - - - 4 39 68 - 5.14 - Normal NR - - - VM 
14 Abinesh 13 M 16 
Days 
+ + + - - 38 104 55 + 10.28 - ME NR - - - TBM 
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15 Ramar 17 M 4 Days + + + - - 210 70 35 - 6.9 - Normal NR + - - BM 
16 Kalimuthu 70 M 21 
Days 
+ + + + - 1650 75 24 + 60.25 - ME NR - - - TBM 
17 Karanthamalai 63 M 5 Days + + + - - 5 22 80 - 3.7 - Normal NR - - - VM 
18 Sandhya 14 F 2 Days + - - - - 6 35 90 - 1.82 - Normal NR - - - VM 
19 Sadham 
hussain 
19 M 20 
Days 
+ + + - - 110 70 57 + 6 + Normal NR - - - TBM 
20 shanthi 55 F 20 
Days 
+ + + - - 200 65 43 + 21.3 + Normal NR - - - TBM 
21 Veeraiyah 36 M 4 Days + + + - - 18 30 56 - 3.2 - Normal NR - - - VM 
22 Palkis 19 F 5 Days - - - - - 15 23 58 - 3.12 - Normal NR - - - VM 
23 Abuthahir 45 M 2 Days + + + - - 150 97 30 + 5.4 - ME NR + - - BM 
24 Havamma 69 F 3 Days + + + - - 158 51 29 - 5 - ME NR + - - BM 
25 Subramniam 60 M 2 Days + - - - - 5 28 59 - 2.2 - Normal NR - - - VM 
26 Tamilselvi 33 F 5 Days + + + - - 200 60 40 - 5.5 - ME NR - - - BM 
27 RajaMani 56 F 10 
Days 
+ + + - - 70 90 40 + 84.3 + BE NR - - - TBM 
28 Rajendra  
Kumar 
27 M  
3 Days 
 
- 
 
- 
 
- 
- - 250 62 38 - 4.5 - Normal NR + - - BM 
29 Meenakshi 50 F 30 
Days 
+ - - - - 30 72 30 + 13.7 + Normal NR - - - TBM 
30 Banumathi 53 F 6 Days - - - - - 20 30 62 - 2.1 - Normal NR - - - BM 
31 Laser 35 M 15 
Days 
+ + + - - 30 70 50 + 16.8 - Normal R - - - TBM 
32 Mohammed 34 M 14 
Days 
+ + - - - 24 68 22 + 26.4 + Normal NR - - - TBM 
33 Sathish 18 M 4 Days + - - - - 16 30 52 - 1.96 - Normal NR - - - VM 
34 Karpagam 40 F 20 
Days 
+ - - - - 34 80 36 + 17.3 + Normal NR - - - TBM 
35 Anitha 26 F 12 
Days 
+ + + + + 100 140 30 + 7.2 + BE, ME NR - - - TBM 
36 Karuppusamy 15 M 2 Days + + + - - 240 60 20 - 6.4 - Normal NR + - - BM 
37 Geetha 35 F 5 Days - - - - - 20 36 66 - 3.4 - Normal NR - - - VM 
38 Arumugam 42 M 4 Days + - - - - 160 70 18 - 5.04 - Normal NR + - - BM 
39 Rajamurugan 20 M 5 Days - - - - - 120 54 38 - 4.38 - Normal NR - - - BM 
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40 Saravanan 36 M 17 
Days 
+ + - - - 40 86 42 + 32.16 + Normal NR - - - TBM 
41 Rajesh 24 M 23 
Days 
+ - - - - 46 68 36 + 29.23 + Normal NR - - - TBM 
42 Saroja 32 F 6 Days + + + - - 20 40 62 - 1.54 - Normal NR - - - VM 
43 Marimuthu 19 M 2 Days + + - - - 146 56 22 - 3.92 - ME NR + - - BM 
44 Ibrahim 47 M 30 
Days 
+ + + + + 40 100 42 - 17.68 - ME, BE R - - - TBM 
45 Ramasamy 60 M 7 Days + - - - - 18 36 70 - 2.14 - Normal NR - - - VM 
46 Manju 21 F 6 Days + - - - - 250 46 30 - 4.32 - Normal NR + - - BM 
47 Sakunthala 34 F 21 
Days 
+ + + - - 80 58 40 + 36.42 + Normal NR - - - TBM 
48 Manikkam 49 M 4 Days + + + - - 180 54 20 - 3.1 - Normal NR - - - BM 
49 Valarmathi 27 F 2 Days + - - - - 16 40 57 - 1.23 - Normal NR - - - VM 
50 Palaniappan 54 M 60 
Days 
+ - - - - 70 62 32 - 21.46 + Normal NR - - - TBM 
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ABBREVIATIONS 
+    - Present 
-                  - Absent 
ADA  -  Adenosine Deaminase 
AFB  -  Acid Fast Bacilli 
BE  -  Basal Exudates 
BM  -  Bacterial meningitis 
CSF  -  Cerebrospinal fluid 
CT  -  Computed Tomography 
FND  -  Focal Neurological Deficit 
HIV  -  Human Immunodeficiency Virus 
LP   - Lumbar Puncture 
ME  -  Meningeal Enhancement 
MRI  -  Magnetic Resonance Imaging 
Mx  -  Mantoux  
NR  -  Non Reactive 
PCR  -  Polymerase chain reaction 
R   -  Reactive 
TBM  -  Tuberculous meningitis 
VCTC  -  Voluntary Testing and Counselling Centre 
VM  -  Viral meningitis 
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ETHICAL CLEARANCE APPROVAL 
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ANTI-PLAGIARISM CERTIFICATE 
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